Kymera Therapeutics, Inc. KYMR
- KT-621 — Atopic Dermatitis Phase 2
- KT-621 — Asthma Phase 2
STAT6 (3 companies · 4 programs)
Companies with an active program directed at STAT6.
ENANTA PHARMACEUTICALS INC ENTA
- EPS-3903 — Atopic Dermatitis Preclinical
Nurix Therapeutics, Inc. NRIX
- NX-3911 Preclinical